StockNews.com initiated coverage on shares of Flanigan’s Enterprises (NYSEAMERICAN:BDL – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the stock.
Flanigan’s Enterprises Stock Performance
Shares of BDL opened at $25.09 on Thursday. Flanigan’s Enterprises has a 12 month low of $24.32 and a 12 month high of $29.72. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.21 and a current ratio of 1.57.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Flanigan’s Enterprises stock. Empowered Funds LLC grew its stake in shares of Flanigan’s Enterprises, Inc. (NYSEAMERICAN:BDL – Free Report) by 5.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,030 shares of the company’s stock after purchasing an additional 670 shares during the quarter. Empowered Funds LLC’s holdings in Flanigan’s Enterprises were worth $375,000 as of its most recent filing with the Securities and Exchange Commission. 11.03% of the stock is currently owned by institutional investors and hedge funds.
About Flanigan’s Enterprises
Flanigan’s Enterprises, Inc, together with its subsidiaries, operates a chain of full-service restaurants and package liquor stores in South Florida. The company operates in two segments, Package Stores and Restaurants. It operates package liquor stores under the Big Daddy’s Liquors name, which offer private label liquors, beer, and wines; and restaurants under the Flanigan’s Seafood Bar and Grill service mark that provide alcoholic beverages and full food services.
Further Reading
- Five stocks we like better than Flanigan’s Enterprises
- Breakout Stocks: What They Are and How to Identify Them
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is the Australian Securities Exchange (ASX)
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Stock Analyst Ratings and Canadian Analyst Ratings
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Flanigan's Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flanigan's Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.